You are here:BitDCA > Events & Conferences

Immix... recnac latceroloc ni 011-XMI r

BitDCA2025-06-10 05:12:45【Events & Conferences】1views

OverviewImmix Biopharma (NASDAQ:IMMX) reported early interim data from a phase 1b/2a trial of IMX-110 in com

Immix Biopharma (NASDAQ:IMMX) reported early interim data from a phase 1b/2a trial of IMX-110 in combination with Novartis (NYSE:NVS) and BeiGene's (NASDAQ:BGNE) tislelizumab to treat patients with ad... Stay informed with the latest.

Liked by (53564)users